04:06 PM EDT, 06/10/2024 (MT Newswires) -- Leonard S Schleifer, Director, Board Co-Chair, President & CEO, on June 06, 2024, sold 787 shares in Regeneron Pharmaceuticals ( REGN ) for $798,821. Following the Form 4 filing with the SEC, Schleifer has control over a total of 694,559 shares of the company, with 466,877 shares held directly and 227,682 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/872589/000188385024000029/xslF345X03/edgardoc.xml